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Hepatic focal lesionAbstract Introduction: Diffusion weighted imaging (DWI) offers molecular information that
complements the morphologic information obtained with conventional magnetic resonance imaging
(MRI) and can reﬂect the functions and structures of the body without trauma.
Aim of the work: To assess the role of DWI as a routine sequence in a MRI study to help in dif-
ferentiating liver lesions.
Patients and methods: The study included 50 patients referred to do a MRI study to diagnose
and/or to conﬁrm the ultrasonographic or CT ﬁndings of focal hepatic lesions. The examination
was done on 1.5T superconducting magnet MRI machines; Philips Gyroscan Intera version
12.1.1.2 (Best, The Netherlands) and Siemens Magnetom Avanto (Erlangen, Germany) machine.
Results: All studied patients had a focal hepatic lesion either on top of cirrhotic liver or non cir-
rhotic liver. DWI was found to be helpful with the routine MRI sequences to reach the diagnosis.
The ﬁnal diagnosis was conﬁrmed by histopathological examination or follow up.
A cutoff value of ADC for benign lesions was found to be 1.25 · 103 mm2/s.
Conclusions: DWI should be included as a basic sequence in the routine MRI study of the liver as it
helps in diagnosis and so reaching a ﬁnal diagnosis or at least trying to narrow the list of differential
diagnosis.
ª 2013 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.ail.com
288 D.M.M. Emara et al.1. Introduction
MRI plays an increasingly important role in the evaluation of
patients with liver disease because of its high contrast
resolution, lack of ionizing radiation, and the possibility of
performing functional imaging sequences. With advances in
hardware and coil systems, diffusion weighted imaging
(DWI) can now be applied to liver imaging with improved
image quality.1,2
DWI offers molecular information that complements the
morphologic information obtained with conventional MRI,
and can reﬂect the functions and structures of the body with-
out trauma and as an index for assessing the tumor response
to treatment.3–6
1.1. Principles of DW MRI
DWI exploits the random motion of water molecules. In a to-
tally unrestricted environment, water movement would be
completely random, a phenomenon otherwise known as
Brownian motion or free diffusion.7
Within biologic tissues, the movement of water is not com-
pletely random, but rather, is impeded by the interaction with
tissue compartments, cell membranes, and intracellular organ-
elles. For purposes of simpliﬁcation, water movement in tis-
sues may be categorized as intravascular, intracellular, or
extracellular (Fig. 1).1,8
The extent of tissue cellularity and the presence of intact
cell membranes help determine the impedance of water mole-
cule diffusion. Tissue types that have been reported to be asso-
ciated with impeded diffusion include tumor, cytotoxic edema,
abscess, and ﬁbrosis. Tissues with low cellularity or thatFigure 1 Schematic illustrating water molecule movement. In
(A) water molecules in a container alone move randomly
(Brownian motion). In (B) highly cellular tissue impedes the
movement of water molecules. Their movement can be categorized
as intravascular, intracellular, or extracellular. In (C) tissue of low
cellularity or with defective cells permits greater water molecule
movement.1consist of cells with disrupted membranes permit greater
movement of water molecules.6
The spin-echo T2-weighted sequence consists of a 90
radiofrequency (RF) pulse followed by a 180 RF pulse, with
the T2 decay related to transverse relaxation. Measurement
of water diffusion is possible with the application of a
dephasing gradient (diffusion sensitizing gradient) prior to
the 180 RF pulse. A symmetric rephasing gradient is then
applied after the 180 RF pulse (Fig. 2a). In a simpliﬁed
model, the effect of the ﬁrst (dephasing) gradient is cancelled
out by the second (rephasing) gradient in tissues with limited
or impeded water movement, such as the highly cellular tissue
of tumors. Therefore, there is little impact on the overall T2
decay, and the T2 signal of the tissue is maintained. In tissues
with unimpeded water movement (low cellularity tissue),
water molecules may move a considerable distance between
the dephasing and rephasing gradient applications.
Consequently, the mobile water molecules will not be
fully rephased, resulting in a reduction in overall T2 signal
intensity (Fig. 2b).1,61.2. Choice of b values and sequence optimization
Because of the relatively short T2 relaxation time of the nor-
mal liver parenchyma, the b values used for clinical imaging
are typically no higher than 1000 s/mm2. Applying a small dif-
fusion weighting of b less than 100–150 s/mm2 nulls the intra-
hepatic vascular signal, creating the so-called black-blood
images, which improve the detection of focal liver lesions
(Fig. 3) while higher b values (P500 s/mm2) give diffusion
information that helps in focal liver lesion characterization.
Hence, when performing DW MR imaging in the liver, it is
advantageous to perform imaging by using both lower
and higher b values (e.g., b P 50, bP 100, and bP 500 s/
mm2).9–12
1.3. Qualitative visual assessment
Visual assessment is helpful for disease detection and charac-
terization by observing the differential signal attenuation be-
tween tissues on DW MRI. Cellular tissues will demonstrate
restricted diffusion (high signal intensity) and lower ADC
values.11.4. Quantitative analysis of DWI ﬁndings and ADC
The ADC represents the slope (gradient) of a line that is
produced when the logarithm of relative signal intensity of
tissue is plotted along the y-axis versus b values along the
x-axis thereby linearizing the exponential decay function.
Quantitative analysis of diffusion-weighted imaging ﬁndings
can be performed only if at least two b values are used for
imaging.13–15
The analysis of ADC is an automated process that is
available as an application on most scanners or on a worksta-
tion. The ADC can then be displayed as a parametric map
and essentially reﬂects differences in tissue diffusivity at
different b values. ADC measurements are then recorded
Figure 2 (a) Schematic illustrating the effect of a diffusion-
weighted sequence on water molecules (solid circles) within highly
cellular tissue or a restricted environment. The diffusion-weighted
sequence is fundamentally a T2-weighted sequence with the
application of a dephasing gradient (diffusion sensitizing gradient)
prior to the 180 RF pulse, followed by a symmetric rephasing
gradient after the 180 pulse. Water molecules within a restricted
environment do not move long distances and acquire phase shifts
during the application of the ﬁrst gradient that are cancelled out
by phase shifts acquired during the second (opposing) gradient. As
a result, no net loss in signal intensity occurs (aside from normal
T2 decay).1 (b) Schematic illustrating the effect of a diffusion-
weighted sequence on water molecules (solid circles) within tissue
with low cellularity or a less restricted environment. Water
molecules within a less restricted environment can move long
distances. Such highly mobile molecules acquire phase informa-
tion from the ﬁrst gradient, but because of their motion, their
signal does not completely rephase with the second gradient,
resulting in a net loss in signal intensity in addition to normal T2
decay SE = spin-echo.1
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map.1,6
However, the signal intensity observed on the diffusion im-
age is dependent on both the water proton diffusivity and the
tissue T2-relaxation time, which is a possible confounding
factor. This means that a lesion may appear to show restricted
diffusion on DW MR Images because of the long T2-relaxa-
tion time rather than the limited mobility of the water protons
(T2 shine-through). This phenomenon can be observed in the
normal gallbladder, cystic lesions, and hemangiomas. The
presence of T2 shine-through is recognized by correlating
high-b-value images with the ADC map. Areas demonstrating
substantial T2 shine-through rather than restricted diffusionwill show high diffusivity on the ADC map and high ADC val-
ues (Figs. 4 and 5).2
Areas of true restricted diffusion demonstrate high signal
intensity on diffusion-weighted images with corresponding
low signal intensity on the ADC map; areas of relatively free
diffusion also appear bright on diffusion-weighted images, cor-
responding to T2 shine-through effects, but will also stay
bright on the ADC map.62. Methods
2.1. Study population
The study population included 50 patients referred to do MRI
study to diagnose and/or to conﬁrm the ultrasonographic or
CT ﬁndings of focal hepatic lesions.
2.2. Imaging technique
All patients had ultrasound as a routine examination (showing
the lesions), CT was done to diagnose these lesions and to con-
ﬁrm or further characterize the CT ﬁndings, MRI was done.
Ultrasound examination was done for all patients to show
whether the liver is cirrhotic or not, to diagnose the presence of
the hepatic lesion and if there is any other abnormalities in the
abdomen, e.g., enlarged LN, ascites other lesions in the spleen,
kidney or pancreas.
Triphasic CT of the liver was done for all patients who
helped in the diagnosis of hypervascular lesions as HCC, focal
nodular hyperplasia (FNH) which was evident in the hepatic
arterial phase (HAP) and other lesions such as metastases
which were evident in the portal venous phase (PVP) and the
delayed phase. Hemangiomas and focal conﬂuent ﬁbrosis were
evident by their enhancement dynamics in the three phases
mainly delayed ﬁlling in.
2.3. MRI imaging
All patients in this study were imaged using 1.5T superconduc-
ting magnet MRI machines; Philips Gyroscan Intera version
12.1.1.2 (Best, The Netherlands) and Siemens Magnetom
Avanto (Erlangen, Germany).
Pre scanning fasting was done for at least 4 h and patients
were instructed about the examination and its time, and how
to take and keep a deep breath which is required in certain
sequences e.g., triphasic study after contrast injection.
The patient was placed in the supine position; arms
extended above the head. A phased array surface coil was
used. Respiratory-gated acquisitions were used in some
sequences. Typical scan time was 20–30 min.
2.4. Scanning parameters
s Localizing T1-W gradient echo sequences were used.
s Axial 2D T2-W turbo spin echo (HASTE/TSE) fat suppres-
sion sequence from the level of lower chest to the mid abdo-
men level as ﬁnishing the whole liver span. TR1600, TE 70,
ﬂip angle 90, FOV 375, slice thickness 7 mm., NSA 1 total
scan time averaging 43 s.
Figure 3 Lesion detection with DW MR imaging versus T2-weighted imaging. Transverse fat-suppressed (left) turbo SE T2-weighted
image and (right) single-shot SE echo-planar diffusion image (b 5 · 100 s/mm2) in a 54-year-old man with colorectal cancer. Application of
diffusion weighting with small b value eliminates the high signal intensity from the intrahepatic vasculature, which makes the metastasis
(arrows) in the caudate lobe of the liver more conspicuous on DW MR image than on T2-weighted image.1,13
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sion sequence with longer TE = 190.
s In-phase and opposed phase (IP/OP) sequence. TR 500, TE
4.6, FOV 375, ﬂip angle 80, slice thickness 7 mm, NSA 2,
average scanning time 48 s.
s SSFP (BFFE in Philips). TR 500, TE 60, ﬂip angle 60, FOV
255, slice thickness 7 mm, NSA 1 with average scan time of
22 s.
s DWI with variable b values 50–1000 s/mm2 with TR 1000,
TE 137, ﬂip angle 90, FOV 370, slice thickness 10 mm
and average scan time 1.15 min.
s 3D T1 spoiled gradient fat suppression sequence (THRIVE
in Philips and VIBE in Siemens) with TR 50,TE 500, FOV
355, ﬂip angle 10, slice thickness 3 mm with average scan
time 19 s and this is repeated in the triphasic study as
HAP (15 s after the end of contrast injection), PVP (70 s
from the end of contrast injection) and delayed phase
(about 3 min from the end of contrast injection) and this
delayed phase may be repeated if indicated in certain cases
e.g., with ﬁbrous components as cholangiocarcinoma or
metastasis with ﬁbrous tissues2.5. Post processing and interpretation
The source images were transferred to a dedicated worksta-
tion for post-processing. The two dimensional series served
to provide detailed anatomical data and reference scans.
DWI was interpreted in correlation with ADC amp and
ADC value was calculated in 103 mm2/s. Multiplanner
reconstruction (MPR) was used to interpret T1 spoiled gradi-
ent sequence in 3D triphasic study (pre and post contrast
phases). All sequences were interpreted and ﬁnally we
reached the diagnosis which was conﬁrmed by histopatholo-
gical ﬁndings in indicated cases or by follow up.
3. Results
Out of the 50 patients included in this study 34 were males and
16 were females.
The age of the studied patient ranged from 25 to 78 years
with a mean age of 53.5 years Fig. 6.
The distribution of focal hepatic lesions was as follows in
the pie chart (Fig. 7).Description of imaging ﬁndings and their correlation with
pathology and or follow up:
One patient had a dysplastic nodule which was large in size
and showed no diffusion restriction. This patient was
diagnosed by CT as HCC while MRI showed the classic signal
intensity of the dysplastic nodules (T2 hypointense, T1
hyperintense) with no diffusion restriction, enhancement in
HAP with gradual fading in PVP and delayed phase (Fig. 8).
Histopathological examination conﬁrmed the MRI diagnosis
of dysplastic nodule.
Three patients had focal conﬂuent ﬁbrosis with characteris-
tic delayed enhancement and no diffusion restriction with ADC
ranging from 1.4 to 1.6 · 103 mm2/s (Fig. 9). Patients with fo-
cal conﬂuent ﬁbrosis showed the lesions in CT but to conﬁrm
this diagnosis, especially in patients with cirrhotic livers and
suspicion of HCC, MRI was done. This latter showed the char-
acteristic signal intensity of the lesions with no diffusion restric-
tion as well as delayed enhancement and also excluded the
presence of HCC.
One patient had post TACE scar showing minor foci of
activity that shows diffusion restriction and ADC= 1 · 103
mm2/s. In this patient the CT showed no activity while MRI
showed minor activity.
Twenty patients had HCC on top of cirrhotic livers show-
ing the typical ﬁndings of HCC with diffusion restriction and
ADC value ranging from 0.7 to 1.1 · 103 mm2/s (Fig. 10).
In patients with HCC the two dynamic studies (triphasic
CT and MRI) were enough for diagnosis of HCC with no need
for further histopathological evaluation.
One HCC case showed portal vein malignant
thrombus that showed the same enhancement dynamics, diffu-
sion restriction and ADC value of the main (HCC) lesion
(Fig. 11).
Five patients had metastases from different primaries.
Some of these metastases showed delayed enhancement reﬂect-
ing the presence of ﬁbrous components, and there was diffu-
sion restriction of these lesions of ADC ranging from 0.8 to
1.4 · 103 mm2/s (Fig. 12).
In patients with metastases we relied on the history of pri-
mary tumor and the presence of multiple hepatic lesions on top
of non cirrhotic liver to conﬁrm the diagnosis. All cases with
metastases on follow up showed either stationary or regressive
course of the disease.
Figure 4 T2 shine-through effect with DW MR imaging. (a) Transverse fat-suppressed breath-hold singleshot SE echo-planar diffusion
image (b 5 · 500 s/mm2) and (b) corresponding ADC map in a 60-year-old woman with metastatic liver disease. Liver metastasis (arrow),
renal cyst, and the gallbladder (*) show high signal intensity on a. This is clariﬁed on b, where the metastasis shows low diffusivity reﬂected
by the low ADC, while the cyst and the gallbladder show high ADC, not because of restricted water diffusion, but because of the long T2
relaxation time of the ﬂuid (T2 shine-through).2
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ferent nature of the hepatic lesions in the same case as some of
them showed cystic changes with a relative decrease in the dif-
fusion restriction and elevated ADC value.
One patient had epitheliod-hemangioendothelioma with
characteristic target enhancement and capsular retraction with
ADC= 0.8 · 103 mm2/s. As EHE is not common histopa-
thological assessment was done to conﬁrm the radiological
diagnosis (Fig. 13).
Two patients had cholangiocarcinoma with typical features
of delayed centripetal ﬁlling in and diffusion restriction with
ADC ranging from 0.7 to 1.3 · 103 mm2/s (Fig. 14). Histopa-
thological ﬁndings in the two cases conﬁrmed the radiological
ﬁndings.
MRI with MRCP was superior to CT to diagnose
cholangiocarcinoma mainly diagnosis of the exact level ofFigure 5 Visual liver lesion characterization with DW MR
imaging. This ﬁgure gives a simpliﬁed approach to lesion
characterization by using visual assessment with b of 0 s/mm2
and a higher b value and ADC maps. A benign ﬂuid-containing
lesion shows a strong signal decrease with high ADC, whereas a
cellular malignant lesion shows no or minimal signal decrease,
with low ADC compared with the surrounding liver parenchyma.
A lesion with long T2 can sometimes show a T2 shine through
effect (see text for explanations). Black circles are hypointense,
white circles are hyperintense.2biliary tract involvement and whether it is central or
peripheral.
Four patients had focal nodular hyperplasia (FNH) with
typical signal intensity and enhancement dynamics as well as
no diffusion restriction with ADC ranging from 1.4 to
1.8 · 103 mm2/s (Fig. 15).
In FNH patients both CT and MRI showed the same
enhancement dynamics (blush enhancement in HAP with
gradual fading till the delayed phase as well as delayed central
scar enhancement) yet the MRI was superior to CT in the diag-
nosis of central scar as it expressed T2 hyperintense signal
which differentiated it from ﬁbrolamellar carcinoma that
showed T2 hypointense scar. So MRI is of great help to differ-
entiate the scar of FNH from ﬁbrolamellar carcinoma depend-
ing on scar and DWI.
Follow up of the four patients with FNH showed no signif-
icant changes in size, signal intensity or enhancement pattern
of the lesions.
Two patients had ﬁbrolamellar carcinoma on top of the
non cirrhotic liver showing the typical signal intensity,n
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Figure 6 Distribution of the studied group according to their age
in relation to the sex.
Classification of the studied FHLs 
Figure 7 Distribution of the studied focal hepatic lesions. \HCC: hepatocellular carcinoma \METS: metastases. \EHE: epithelioid-
hemangioendothelioma. *FNH: focal nodular hyperplasia \TACE: transarterial chemoembolization.
Figure 8 Male patient 71 years with cirrhotic liver showing a well deﬁned dysplastic nodule at segment VI showing no diffusion
restriction (arrow in a) enhancement in HAP (arrow in b) and gradual fading in the delayed phase (arrow in c).
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and diffusion restriction with ADC ranging from 1.1 to
1.2 · 103 mm2/s (Fig. 16).
One patient with lymphoma showed marked diffusion
restriction of the hepatic lesions and low ADC= 0.6 · 103
mm2/s.This patient had multiple hepatic and splenic lesions with
marked diffusion restriction of these lesions and very low
ADC value. These ﬁndings together with enlarged retroperito-
neal lymph nodes were enough for the diagnosis of lymphoma
and histopathological ﬁndings conﬁrmed the radiological
diagnosis (Fig. 17).
Figure 9 Male patient 53 years with focal conﬂuent ﬁbrosis showing a focal lesion at segment VII hyperintense in DWI (arrow in a) and
hyperintense in ADC with its value averaging 1.6 · 103 mm2/s (b), the lesion showing no deﬁnite enhancement in HAP (arrow in c) yet in
the delayed phase it took delayed mild enhancement (arrow in d).
Figure 10 Male patient 40 years showing a classic partially exophytic HCC at segment VI on top of cirrhotic liver showing diffusion
restriction in DWI (arrow in a) with ADC value averaging 0.9 · 103 mm2/s (b) washin washout enhancement dynamics with delayed
capsular enhancement in the triphasic study (arrows in c and d).
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in a non contrast study as well as enhancement dynamics after
contrast injection; they showed no diffusion restriction withcharacteristic T2 shine through effect with ADC ranging from
1.4 to 2.5 · 103 mm2/s and this was enough for diagnosis of
hemangioma with no need for biopsy (Fig. 18).
Figure 11 Male patient 51 years showing subcapsular HCC at the hepatic dome with diffusion restriction in DWI (arrow in a) and low
ADC (arrow in b), malignant portal vein thrombus is also noted showing diffusion restriction (curved arrow in c) with ADC value
averaging 0.9 · 103 mm2/s (d) the malignant thrombus showing the same enhancement dynamics of the main lesion i.e., washin washout
pattern (curved arrow in e and f) the main lesion in the delayed phase showing washout with delayed capsular enhancement (arrow in g).
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Figure 12 Male patient 78 years with hepatic metastases from colon cancer showing two focal hepatic lesions at segments VI (arrows in a
and b) persistent diffusion restriction in high b values (b= 1000, (arrows in b). Also note low ADC value averaging 1 · 103 mm2/s.
Figure 13 Male patient 49 years with EHE showing diffusion restriction of the hepatic and splenic lesions (arrows in a) with ADC value
averaging 0.8 · 103 mm2/s (b) conﬁrmed by histopathological correlation. (c) Epithelioid hemangioendothelioma. Clusters of tumor cells
with abundant eosinophilic cytoplasm and hyperchromatic nuclei are seen embedded in a ﬁbrotic stroma. Some of the tumor cells contain
cytoplasmic vacuoles representing vascular lumen (arrows). (H&E stain. Original magniﬁcation ·100).
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tient, HCC and hemangioma, DWI was of great help with the
dynamic study to conﬁrm the diagnosis, it showed T2 shine
through the effect of hemangioma and true diffusion restric-
tion of HCC (Fig. 19).
One patient had multiple hepatic abscesses showing marked
diffusion restriction with low ADC= 0.8 · 103 mm2/s. In
this patient clinical data in correlation with the MRI ﬁndings
were in favor of the diagnosis of hepatic abscesses which was
conﬁrmed by cytological examination of the aspirate from
the lesion.
3.1. ADC value
The ADC value of benign lesions ranged from 0.8 to
2.5 · 103 mm2/s while that of the malignant lesions ranged
from 0.6 to 1.4 · 103 mm2/s. The low ADC value in benign
lesions is attributed to hepatic abscess with increased viscos-
ity which decrease the diffusibility rather than the cellularity
and on the other hand the high ADC value in malignant le-
sions is attributed to cases with hepatic metastases showing
cystic changes that relatively increased the ADC value, so
from this we found some overlap in ADC value between
the benign and malignant lesions however this is notFigure 14 Female patient 41 years with peripheral cholangiocarcino
1.3 · 103 mm2/s (b) and inﬁltrating & exerting mass effect upon theconfusing when the lesion interpretation does not rely only
on DWI but is done in conjunction with the other MRI se-
quences and in correlation with the patient’s history.
Statistical analysis of ADC value in different lesions
showed the following (Fig. 20).
3.2. Area under curve = 0.947
The cutoff value of ADC for benign lesion is 1.25 · 103 mm2/s,
so lesions with ADC less than 1.25 · 103 mm2/s are malignant
while lesions with ADC value more than 1.25 · 103 mm2/s
are benign with a sensitivity of 90.9% and a speciﬁcity of
90.6%.4. Discussion
In Egypt we are facing the problem of post-hepatitic liver cir-
rhosis with its complications and radiological dilemmas of
different nodular lesions starting from macroregenerative
and dysplastic nodules and ending with HCC. Therefore
the use of the most accurate and less invasive and less
hazardous imaging techniques in diagnosis of these nodular
lesions is our goal.ma showing diffusion restriction (a) with ADC value averaging
biliary radicles in MRCP (dashed arrow in c).
Figure 15 Female patient 34 years with FNH on top of non cirrhotic liver showing no diffusion restriction in DWI (arrow in a) with
ADC value averaging 1.4 · 103 mm2/s (b) intense enhancement in HAP (c) and fading in the delayed phase (d) with delayed central scar
enhancement (arrow in d).
Figure 16 Female patient 50 years with large ﬁbrolamellar carcinoma on top of non cirrhotic liver showing diffusion restriction in DWI
(a) with ADC value averaging 1.1 · 103 mm2/s (b) central T2 hypointense scar (arrow in c) and cytological ﬁndings conﬁrmed the
diagnosis. (d) FNAC of ﬁbrolamellar carcinoma showing tumor cells with abundant eosinophilic cytoplasm embedded in an eosinophilic
background and admixed with few spindled ﬁbroblasts (arrow). (H&E stain. Original magniﬁcation ·400).
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Figure 17 Male patient 56 years with NHL showing multiple lesions inﬁltrating both lobes of the liver showing diffusion restriction in
DWI (a) with low ADC value averaging 0.6 · 103 mm2/s (b), portahepatis and peripancreatic enlarged amalgamated lymph nodes are
also noted (arrow in c), also note left renal lesion (dashed arrow in c). Pathologically proved to be NHL (d) Two liver cores from the same
patient with NHL, illustrating the nodular pattern of the inﬁltrate; the liver core on the left side is inﬁltrated by a neoplastic lymphoid
population, while the core on the right shows unremarkable hepatocytes. (H&E stain. Original magniﬁcation ·100).
298 D.M.M. Emara et al.DWI in conjunction with the routine MRI sequences
helped us in our cases to differentiate regenerative/dysplastic
nodules from early small HCC focus which is of great beneﬁt
to the patients in their management.
In addition to the lesions which commonly occur on top of
cirrhotic livers there are also other common lesions not associ-
ated with cirrhosis such as metastases, hemangioma and FNH
that need accurate non-invasive diagnosis for proper manage-
ment of the patient. With the use of a triphasic CT we can accu-
rately diagnose most of these lesions however the use of MRI
with different pulse sequences, triphasic study as well as DWI,
which reﬂect the cellularity of the lesions, and without exposure
to radiation helped us to reach the accurate diagnosis.
MRI of the liver is an important tool for the detection and
characterization of focal liver lesions. With recent advances in
technology, functional MRI methods such as DW is increas-
ingly used in the abdomen with promising results, particularly
in the evaluation of focal liver diseases.9,15,16
However, although MRI is more superior and less hazard-
ous than CT in the diagnosis of hepatic lesions, it needs a
cooperative patient in a relatively longer time of examination
when compared with CT and also it is more expensive than
CT especially if not covered by health insurance.
DWI may depict and help characterize focal hepatic lesions.
A small amount of diffusion weighting with a low b value(<200 s/mm2) nulls the intrahepatic vascular signal intensity,
creating the so-called black-blood images and improve depiction
of focal liver lesions. Studies have demonstrated the superiority
of DWI over T2-weighted MR imaging for depiction of le-
sions.9,17 Images with higher b values provide diffusion informa-
tion that aids in lesion characterization.9,17 Malignant lesions
have lower mean ADC values than benign lesions, with varying
degrees of overlap.9,18,19 In our studywedepended uponDWIof
both low and high b values in interpretation of the lesion: with
low b value, the lesion detectability was high and with the high
b value, the lesion characterization was better. This is in associ-
ationwith the quantitativemethod, i.e., theADCvalue helped in
differentiating benign from malignant lesions.
In our study, we found an overlap in ADC value between
benign and malignant lesions such as in hepatic abscess as it
is a benign lesion but with low ADC and in cases of cystic
changes of hepatic metastasis with relatively increased ADC
value although it is a malignant lesion. This is in agreement
with Parikh T DS and Lee VS who found some overlap in
ADC value between benign and malignant lesions.9
The cutoff value of the benign lesions in our study was
1.25 · 103 mm2/s with a sensitivity of 90.9% and a speciﬁcity
of 90.6%.
Girometti et al. showed an area under the curve of 0.96,
sensitivity of 92%, speciﬁcity of 100%, positive predictive
Figure 18 Male patient 52 years with hepatic hemangioma on top of non cirrhotic liver showing high signal intensity in DWI (arrow in
a) and high ADC averaging 2 · 103 mm2/s (b), isointense to the aorta in all phases of triphasic study (c–e), wedge shaped area of THID is
noted in HAP (arrow in c).
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of 96% using ADC cutoff of 1.31 · 103 mm2/s2.
DWI is available at most facilities and may be incorporated
into conventional protocols. Information from DWI should al-
ways be interpreted in conjunction with conventional MR
imaging ﬁndings.20,21
Gourtsoyianni et al.19 demonstrated higher liver-to-lesion
signal intensity ratios with small diffusion gradients for
HCC and metastatic lesions. Similarly our results demon-
strated the value of DWI in detection of focal liver lesions
including HCC and metastases, as MRI in HCC patients
showed the same CT ﬁndings but with superior lesion-to-liver
contrast with no exposure to radiation and conﬁdently diag-
nosed the HCC by using different pulse sequences in addition
to DWI.
In one of our cases the patient had both HCC and heman-
gioma, both lesions could be differentiated conﬁdently by theDWI together with other MRI sequences and triphasic study,
and this differentiation is important to select patients that can
undergo liver biopsy.
Results of a study by Low et al.20 have shown increased
detection of metastatic lesions with a combination of DWI
and precontrast T1- and T2-weighted imaging. This is in con-
cordance with our results that highlighted the complementary
role of DWI with routine MRI in diagnosis and characteriza-
tion of metastatic lesions.
Low and Gurney20 published a study recently that demon-
strated the additional detection of tumor foci with DWI com-
pared with that of conventional sequences (pre- and post
contrast imaging), the potential beneﬁt of DWI in association
or comparison with conventional gadolinium-enhanced liver
MRI remains to be investigated. Our study showed the com-
plementary role of diffusion in the detection of primary and
metastatic lesions of the liver.
Figure 19 Male patient 60 years with HCC at the right lobe showing diffusion restriction, hyperintese in DWI (arrow in a) with ADC
value averaging 0.85 · 103 mm2/s (b) and hemangioma at the left lobe showing T2 shine through effect in DWI (dashed arrow in a) with
ADC value averaging 1.8 · 103 mm2/s (c), the hemangioma showing a light bulb appearance in long TE in T2WI (dashed arrow in d)
while HCC showing less T2 hyperintense signal (arrow in d), the hemangioma showing peripheral enhancement in HAP (dashed arrow in
e) with gradual ﬁlling in PVP and delayed phase (dashed arrow in f and g respectively) while HCC showing washin washout enhancement
dynamics (arrow in e–g).
300 D.M.M. Emara et al.DWI enabled us to discriminate between bland and neo-
plastic portal vein thrombus in a case of HCC, as the
thrombus showed similar signal intensity as the primary
HCC when qualitative analysis was performed. This was
previously mentioned by Parikh et al.9 and by Onofrio
et al.22.5. Conclusion
DWI is an important complementary sequence with the rou-
tine MRI of the liver that helps in lesion quantiﬁcation and
characterization in a hope to reach ﬁnal conﬁdent diagnosis
and in order to reduce the rate of biopsy.
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Figure 20 ROC curve of ADC of benign lesions.
Is diffusion weighted imaging adding value in diagnosis of focal hepatic lesions? Experience in 50 patients 301The use of a quantitative method using ADC value with a
cutoff point of 1.25 · 103 mm2/s is helpful in differentiating
benign from malignant lesions.
Although the MRI is a safe technique without exposure to
radiation it has some disadvantages as the examination takes
longer time than in CT and it is also more expensive than
CT especially in our country with limited resources.
Therefore, MRI and DWI should be used in selected lesions
where their use would add beneﬁt to the patient.
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